Simon P. Früh

Simon P. Früh

Auto-generated profile, based on publicly available information

Simon P. Früh

Baker Institute for Animal Health and Department of Microbiology and Immunology, Cornell University College of Veterinary Medicine, Ithaca, NY 2

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
KSKatherine M. Still
Katherine M. Still
SBSamantha J. Batista
Samantha J. Batista
COCarleigh A. O’bRien
Carleigh A. O’bRien
OOOyebola O. Oyesola
Oyebola O. Oyesola
SFSimon P. Früh
Simon P. Früh
THTajie H. Harris
Tajie H. Harris
It is of great interest to understand how invading pathogens are sensed within the brain, a tissue with unique challenges to mounting an immune response. The eukaryotic parasiteToxoplasma gondiicolonizes the brain of its hosts, and initiates robust immune cell recruitment, but little is known about pattern recognition ofT.gondiiwithin brain tissue. The host damage signal IL-33 is one protein that has been implicated in control of chronicT.gondiiinfection, but, like many other pattern recognition pathways, IL-33 can signal peripherally, and the specific impact of IL-33 signaling within the brain is unclear. Here, we show that IL-33 is expressed by oligodendrocytes and astrocytes duringT.gondiiinfection, is released locally into the cerebrospinal fluid ofT.gondii-infected animals, and is required for control of infection. IL-33 signaling promotes chemokine expression within brain tissue and is required for the recruitment and/or maintenance of blood-derived anti-parasitic immune cells, including proliferating, IFN-γ-expressing T cells and iNOS-expressing monocytes. Importantly, we find that the beneficial effects of IL-33 during chronic infection are not a result of signaling on infiltrating immune cells, but rather on radio-resistant responders, and specifically, astrocytes. Mice with IL-33 receptor-deficient astrocytes fail to mount an adequate adaptive immune response in the CNS to control parasite burden–demonstrating, genetically, that astrocytes can directly respond to IL-33in vivo. Together, these results indicate a brain-specific mechanism by which IL-33 is released locally, and sensed locally, to engage the peripheral immune system in controlling a pathogen.

20 July 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
OOOyebola O. Oyesola
Oyebola O. Oyesola
MSMichael T. Shanahan
Michael T. Shanahan
MKMatt Kanke
Matt Kanke
BMBridget M. Mooney
Bridget M. Mooney
LWLauren M. Webb
Lauren M. Webb
ETElia Tait-Woijno
Elia Tait-Woijno
Type 2 inflammation is associated with epithelial cell responses, including goblet cell hyperplasia, that promote worm expulsion during intestinal helminth infection. How these epithelial responses are regulated remains incompletely understood. Here, we show that mice deficient in the prostaglandin D2 (PGD2) receptor CRTH2 and mice with CRTH2 deficiency only in nonhematopoietic cells exhibited enhanced worm clearance and intestinal goblet cell hyperplasia following infection with the helminth Nippostrongylus brasiliensis. Small intestinal stem, goblet, and tuft cells expressed CRTH2. CRTH2-deficient small intestinal organoids showed enhanced budding and terminal differentiation to the goblet cell lineage. During helminth infection or in organoids, PGD2 and CRTH2 down-regulated intestinal epithelial Il13ra1 expression and reversed Type 2 cytokine–mediated suppression of epithelial cell proliferation and promotion of goblet cell accumulation. These data show that the PGD2–CRTH2 pathway negatively regulates the Type 2 cytokine–driven epithelial program, revealing a mechanism that can temper the highly inflammatory effects of the anti-helminth response.

15 February 2020 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
OOOyebola O Oyesola
Oyebola O Oyesola
CDCarolina Duque
Carolina Duque
LHLinda C. Huang
Linda C. Huang
ELElisabeth Larson
Elisabeth Larson
SFSimon P. Früh
Simon P. Früh
ETElia Tait-Woijno
Elia Tait-Woijno
Group 2 innate lymphoid cells (ILC2s) are rare innate immune cells that accumulate in tissues during allergy and helminth infection, performing critical effector functions that drive type 2 inflammation. ILC2s express ST2, the receptor for the cytokine IL-33, and chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2), a receptor for the bioactive lipid prostaglandin D2 (PGD2). The IL-33–ST2 and the PGD2–CRTH2 pathways have both been implicated in promoting ILC2 accumulation during type 2 inflammation. However, whether these two pathways coordinate to regulate ILC2 population size in the tissue in vivo remains undefined. In this study, we show that ILC2 accumulation in the murine lung in response to systemic IL-33 treatment was partially dependent on CRTH2. This effect was not a result of reduced ILC2 proliferation, increased apoptosis or cell death, or differences in expression of the ST2 receptor in the absence of CRTH2. Rather, data from adoptive transfer studies suggested that defective accumulation of CRTH2-deficient ILC2s in response to IL-33 was due to altered ILC2 migration patterns. Whereas donor wild-type ILC2s preferentially accumulated in the lungs compared with CRTH2-deficient ILC2s following transfer into IL-33–treated recipients, wild-type and CRTH2-deficient ILC2s accumulated equally in the recipient mediastinal lymph node. These data suggest that CRTH2-dependent effects lie downstream of IL-33, directly affecting the migration of ILC2s into inflamed lung tissues. A better understanding of the complex interactions between the IL-33 and PGD2–CRTH2 pathways that regulate ILC2 population size will be useful in understanding how these pathways could be targeted to treat diseases associated with type 2 inflammation. Key Points IL-33 treatment upregulated PGD2 synthesis genes. IL-33–elicited lung ILC2 accumulation was partially dependent on the PGD2 receptor CRTH2. CRTH2 controlled IL-33–elicited ILC2 lung accumulation via migration/tissue retention.

11 April 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
LWLauren M. Webb
Lauren M. Webb
OOOyebola O. Oyesola
Oyebola O. Oyesola
SFSimon P. Früh
Simon P. Früh
EKElena Kamynina
Elena Kamynina
KSKatherine M. Still
Katherine M. Still
ETElia Tait-Woijno
Elia Tait-Woijno
Type 2 inflammation drives the clearance of gastrointestinal helminth parasites, which infect over two billion people worldwide. Basophils are innate immune cells that support host-protective type 2 inflammation during murine infection with the helminth Trichuris muris. However, the mechanisms required for basophil function and gene expression regulation in this context remain unclear. We show that during T. muris infection, basophils localized to the intestine and up-regulated Notch receptor expression, rendering them sensitive to Notch signals that rapidly regulate gene expression programs. In vitro, Notch inhibition limited basophil cytokine production in response to cytokine stimulation. Basophil-intrinsic Notch signaling was required for T. muris–elicited changes in genome-wide basophil transcriptional programs. Mice lacking basophil-intrinsic functional Notch signaling had impaired worm clearance, decreased intestinal type 2 inflammation, altered basophil localization in the intestine, and decreased CD4+ T helper 2 cell responses following infection. These findings demonstrate that Notch is required for basophil gene expression and effector function associated with helminth expulsion during type 2 inflammation. Graphical Abstract